Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Biotech
Zealand's Zupreme serves up to 10.7% mean weight loss
“Its placebo-like tolerability exceeds our expectations and, combined with double-digit weight reduction, sets a new standard,” Zealand's CEO said.
Gabrielle Masson
Mar 5, 2026 4:44pm
How GLP-1s help the heart relax: study
Mar 2, 2026 7:01pm
AstraZeneca's oral GLP-1 scored phase 2 wins, but no data yet
Feb 10, 2026 9:58am
Kailera, Hengrui to advance oral obesity drug into 2 new trials
Feb 10, 2026 9:25am
Pfizer links monthly GLP-1 to competitive weight loss in phase 2
Feb 3, 2026 8:45am
Novo’s CagriSema tops semaglutide in ph. 3 diabetes study
Feb 2, 2026 3:01pm
